Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Connect Biopharma Holdings Inc | CNTB | NASDAQ | Depository Receipt |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
1,45 | 1,33 | 1,45 | 1,37 | 1,39 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
28.2.2024 | 03:00 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
13.2.2024 | 22:30 | EDGAR2 | Form SC 13D - General statement of acquisition of beneficial.. |
13.2.2024 | 22:27 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
13.2.2024 | 22:18 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
12.2.2024 | 22:50 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12.12.2023 | 12:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
21.11.2023 | 12:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
01.11.2023 | 20:57 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
20.10.2023 | 22:44 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12.9.2023 | 22:47 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12.9.2023 | 12:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14.7.2023 | 23:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |